DossierHypothesis

Caffeic-acid phenethyl ester (CAPE) — aging-program reverser dossier

Measured +0.141 selective reversal (cytotox align +0.12). Modest signal — aging is a weak-reversal target; treat as a soft signal.

Research intelligence — a ranked, filtered hypothesis, not a validated cure. No disease or efficacy claim. Computational transcriptomic prediction, pending wet-lab.

Mechanism

Selective reversal of an aging (GSE107037) gene-expression program

Validation state

Hypothesis — Computational transcriptomic prediction. Pending wet-lab. The engine's default output.

Tox gate

Clean (Brenk/PAINS/NIH + cytotox + carcinogen blocklist)

Trial whitespace

Untried (whitespace) — 0 verified aging/longevity interventional trials. Propolis-derived NP → supplement (Lane B) eligible.

IP class

Natural product — GRAS/food/NP — supplement (Lane B) eligible.

Headline

Propolis-derived NP · selective aging-program reverser · DSHEA structure-function candidate

Computational hypothesis· 2026-06-02

Related listings

Same mechanism or overlapping tags. Computational, pending wet-lab.

Genome-to-compound: the cordycepin/pentostatin biosynthetic gene cluster (Cns1–4) called from the Cordyceps militaris genome → cordycepin (3'-deoxyadenosine)

Cordycepin (Cordyceps militaris) — genome-discovered natural product dossier

Genome → BGC (Cns1–4) → cordycepin · computational prediction, pending wet-lab · public off-patent natural product · a genotype→chemotype teaching case

antioxidant / redox

alpha-lipoic acid — acute kidney injury

GRAVEYARD · 1 trials · supplement

antioxidant / redox

alpha-lipoic acid — age-related macular degeneration

GRAVEYARD · 1 trials · supplement

antioxidant / redox

alpha-lipoic acid — Alzheimer disease

GRAVEYARD · 3 trials · supplement

Full intelligence is gated

Unlock the full dossier on the Exchange.

The full dossier — ranked candidate lists, measured-selectivity detail, published-literature corroboration, and known-compound structures — is delivered as a PDF to your checkout email. The teaser and the free academic package above are always public.

Buy this dossier →

Provenance: Real artifact: WHITESPACE_DISCOVERY_BUSINESS_MODEL_v1.md Appendix (aging registry comparison, GSE107037). CAPE structure is public prior art. · Updated 2026-06-02.
Research intelligence, not medical, efficacy, or freedom-to-operate advice. All candidate signals are computational transcriptomic predictions pending wet-lab validation. The subscriber owns development and claims decisions and is responsible for its own freedom-to-operate. CONFIDENTIAL — MightyCloud Collective / OmniRayn Foundry.